Dronedarone
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Dronedarone and local guidelines before prescribing.
Mechanism
Multichannel antiarrhythmic related to amiodarone.
Uses
Paroxysmal and persistent AF maintenance in selected patients.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Diarrhoea, nausea, raised creatinine, hepatotoxicity, QT prolongation, heart failure.
Interactions
Strong CYP3A4 inhibitors; dabigatran levels rise; digoxin.
Contraindications and cautions
Heart failure, permanent AF, liver disease
Monitoring
LFT, ECG, creatinine
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Avoid in severe hepatic impairment
Overdose and reversal
Supportive
Special advice
Contraindicated in permanent AF and unstable heart failure; LFT monitoring.
More from the textbook: uses, cautions and other points
- Antiarrhythmic maintenance: Selected use of beta blockers, flecainide, dronedarone, sotalol or amiodarone according to heart disease, QT, renal function and interactions.
Cardiology: Cardiac Arrhythmias - Interactions - avoid with strong CYP3A4 and P-glycoprotein inhibitors (ketoconazole, itraconazole, some HIV drugs) and inducers ( rifampicin , carbamazepine , phenytoin , St John's wort - levels fall); bleeding risk with antiplatelets, NSAIDs and SSRIs; dronedarone and verapamil affect some.
Haematology: Anatomy Physiology and Pharmacology - III | Potassium channel block, prolong repolarisation - amiodarone , sotalol , dronedarone | Amiodarone for AF and VT (see below); sotalol - QT prolongation, torsades (check QTc and kidney function)
Cardiology: Anatomy Physiology and Pharmacology - Antiarrhythmics - amiodarone, sotalol, flecainide, dronedarone.
Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy - NSAIDs , pioglitazone , non-dihydropyridine calcium channel blockers (verapamil, diltiazem - in reduced EF), class I antiarrhythmics (flecainide), dronedarone (severe HF), tricyclics, itraconazole, high-sodium preparations, some chemotherapy (anthracyclines, trastuzumab).
Clinical pharmacology and prescribing: Prescribing in special groups
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Cardiology: Cardiac Arrhythmias (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Integrated cardiology chapter (1 mention)